Michelle D. Miller - Nutrition and Dietetics, Clinical and Molecular Medicine, Flinders University

基本信息

浏览量：67

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 66 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Alpelisib in Combination with Trastuzumab and Pertuzumab As Maintenance Therapy in Patients with HER2+, PIK3CA-mutant Advanced Breast Cancer: EPIK-B2 Study Part 1 Safety and Efficacy Results

Sara A. Hurvitz,Francois-Clement Bidard,Wei Li,Xichun Hu,Sonia Pernas,Joseph Thaddeus Beck,Mario Campone,Kevin Punie,Michelle Miller,Mathilde Kaper, Yu Han,Farhat Ghaznawi,Guy Jerusalem

CANCER RESEARCHno. 7 (2023)

引用1浏览0引用

Abstract 4926: Alpelisib in Combination with Trastuzumab and Pertuzumab As Maintenance Therapy in Patients with HER2+, PIK3CA-mutant Advanced Breast Cancer: EPIK-B2 Study Part 1 Safety and Efficacy Results

Sara A. Hurvitz,François-Clement Bidard,Wei Li,Xichun Hu, Sonia Pernas,Joseph Thaddeus Beck,Mario Campone,Kevin Punie,Michelle Miller, Mathilde Kaper, Yu Han,Farhat Ghaznawi, Guy Jerusalem

Cancer Researchno. 7_Supplement (2023): 4926-4926

引用0浏览0引用

Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: an Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical Trials

Yan Ji,Vitaly Yartsev,Michelle Quinlan,Paolo Serra,Yingbo Wang,Abhijit Chakraborty,Michelle Miller

Clinical Pharmacokinetics（2023）

引用4浏览0WOS引用

Abstract P5-02-32: Differential Gene Mutation Landscape in Patients with PIK3CA-altered and Non-altered Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the SOLAR-1 Clinical Study

Dejan Juric,Hope Rugo,Albert Reising,Chong Ma,Eva Ciruelos,Sibylle Loibl,Christian F. Singer,Joo Hyuk Sohn,Mario Campone,PierFranco Conte,Hiroji Iwata,Farhat Ghaznawi,Michelle Miller,Tetiana Taran,Faye Su,Fabrice Andre

Cancer Researchno. 5_Supplement (2023): P5-02

引用1浏览0引用

Post-infection Treatment with the E Protein Inhibitor BIT225 Reduces Disease Severity and Increases Survival of K18-Hace2 Transgenic Mice Infected with a Lethal Dose of SARS-CoV-2

Gary Ewart,Michael M. Bobardt,Bo Hjorth Bentzen,Yannan Yan,Audrey Thomson,Klaus Klumpp,Stephen Becker,Mette Rosenkilde,Michelle Miller,Philippe Gallay

PLOS PATHOGENS（2023）

引用4浏览0WOS引用

Differential Gene Mutation Landscape in Patients with PIK3CA-altered and Non-altered Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the SOLAR-1 Clinical Study

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

275P A Phase II Study of LAG525 in Combination with Spartalizumab (PDR001), PDR001 and Carboplatin (carbo), or Carbo, As First- or Second-Line Therapy in Patients (pts) with Advanced (adv) Triple-Negative Breast Cancer (Tnbc)

L.A. Carey,J-Y. Pierga,S. Kümmel,G. Jerusalem,M. De Laurentiis,M. Miller, Z. Li,M. Kaper,F. Su,S. Loi

Annals of Oncology（2021）

引用5浏览0引用

Clinical outcomes of alpelisib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer with PIK3CA alterations detected in plasma ctDNA by next-generation sequencing: Biomarker analysis from the SOLAR-1 study

Eva M. Ciruelos,Sibylle Loibl,Ingrid A. Mayer,Mario Campone,Hope S. Rugo,Monica Arnedos,Hiroji Iwata,Pier Franco Conte,Fabrice Andre,Albert Reising,Chong Ma,Michelle Miller,Naveen Babbar,Dejan Juric

CANCER RESEARCH（2021）

引用2浏览0引用

Pharmacokinetics of Ribociclib in Subjects with Hepatic Impairment

Tanay S. Samant,Shu Yang,Michelle Miller,Yan Ji

The Journal of Clinical Pharmacology（2021）

引用10浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn